E-LIB Suche - Ergebnisse für: Mödl, Lukas

1

Comparison of clinical outcomes in hospitalized patients wi..:

Meyer, Hans-Jakob ; Mödl, Lukas ; Unruh, Olesya...
Infection. , 2024

Link: https://doi.org/10.1007/..

2

Long-term symptom severity and clinical biomarkers in post-..:

Legler, Franziska ; Meyer-Arndt, Lil ; Mödl, Lukas...
eClinicalMedicine. 63 (2023) - p. 102146 , 2023

Link: https://doi.org/10.1016/..

3

Follow-Up of Men Who Have Undergone Focal Therapy for Prost..:

Mala, Katharina Sophie ; Plage, Henning ; Mödl, Lukas...
Journal of Clinical Medicine. 12 (2023) 22 - p. 7089 , 2023

Link: https://doi.org/10.3390/..

4

Long-term symptom severity and clinical biomarkers in post-..:

Legler, Franziska ; Meyer-Arndt, Lil ; Mödl, Lukas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469383/. , 2023

Link: http://www.ncbi.nlm.nih...

5

The RODEO Approach for Nonparametric Density Estimation:

Mödl, Lukas
http://edoc.hu-berlin.de/18452/23097. , 2021

Link: http://edoc.hu-berlin.de..

6

Long-term symptom severity and clinical biomarkers in post-..:

Franziska Legler ; Lil Meyer-Arndt ; Lukas Mödl...
http://www.sciencedirect.com/science/article/pii/S2589537023003231. , 2023

Link: https://doi.org/10.1016/..

7

Defects in microvillus crosslinking sensitize to colitis an..:

Mödl, Bernadette ; Awad, Monira ; Zwolanek, Daniela...
EMBO reports. 24 (2023) 10 - p. , 2023

Link: https://doi.org/10.15252..

8

Tyk2 is a tumor suppressor in colorectal cancer:

Moritsch, Stefan ; Mödl, Bernadette ; Scharf, Irene...
OncoImmunology. 11 (2022) 1 - p. , 2022

Link: https://doi.org/10.1080/..

9

Defects in microvillus crosslinking sensitize to colitis an..:

Mödl, Bernadette ; Awad, Monira ; Zwolanek, Daniela...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561180/. , 2023

Link: http://www.ncbi.nlm.nih...

10

EMBO Reports / Defects in microvillus crosslinking sensitiz..:

Eferl, Robert ; Mödl, Bernadette ; Awad, Monira...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-87734/128. , 2023

Link: https://doi.org/10.15252..

11

Tyk2 is a tumor suppressor in colorectal cancer:

Stefan Moritsch ; Bernadette Mödl ; Irene Scharf...
https://www.tandfonline.com/doi/10.1080/2162402X.2022.2127271. , 2022

Link: https://doi.org/10.1080/..

12

Tyk2 is a tumor suppressor in colorectal cancer:

Moritsch, Stefan (Medical University of Vienna / Comprehensive Cancer Center) ; Sibilia, Maria (Medical University of Vienna / Comprehensive Cancer Center) ; Casanova, Emilio (Medical University of Vienna / Comprehensive Cancer Center)...
isPartOf:https://phaidra.vetmeduni.ac.at/o:605[Publications / University of Veterinary Medicine Vienna]. , 2022

Link: https://doi.org/10.1080/..

13

Tyk2 is a tumor suppressor in colorectal cancer:

Stefan Moritsch (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) ; Bernadette Mödl (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) ; Irene Scharf (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center)...
hdl:11353/10.1674689. , 2022

Link: https://doi.org/10.1080/..